Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA regulations clearance

This article was originally published in The Gray Sheet

Executive Summary

In a March 29 memo, HHS Secretary Shalala informs Office of Management and Budget Director Leon Panetta that she has "reviewed and approved for publication in the Federal Register" FDA regulations that have been on hold. In January, Panetta put a hold on pending federal regs until Clinton Administration officials could review them. Among approximately 30 FDA regs on hold was the medical device tracking clarification rule ("The Gray Sheet" Feb. 1, I&W-9).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel